Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
MLS-573151
Cat. No.:
OB0225LY-0070
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
MLS-573151 is a small molecule compound that targets specific cancer cell signaling pathways.
Synonym:
10179-57-4; MLS573151; 4-(3,5-Diphenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide; 4-(3,5-Diphenyl-3,4-dihydropyrazol-2-yl)benzenesulfonamide
CAS No.:
10179-57-4
Compound CID:
2837695
Formula:
C21H19N3O2S
Formula Weight:
377.46
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
MLS-573151 can be used to inhibit cancer cell proliferation and promote apoptosis.
Library Information
Targets:
Ras; CDK
Receptors:
Cdc42
Pathways:
Cell cycle/Checkpoint; MAPK; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
h2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
30 mg/mL; 79.48 mM
